The Myositis Activities Profile -- initial validation for assessment of polymyositis/dermatomyositis in the USA

J Rheumatol. 2012 Nov;39(11):2134-41. doi: 10.3899/jrheum.120504. Epub 2012 Sep 1.

Abstract

Objective: To evaluate some measurement properties of the Myositis Activities Profile (MAP) in adult patients with polymyositis (PM) and dermatomyositis (DM) in the United States.

Methods: To assess content validity, patients with PM/DM rated difficulty and importance of items of the MAP using a visual analog scale (VAS), range 0-10. For construct validity, consecutive patients with PM/DM performed the 6-item core set for disease activity including the manual muscle test (MMT) and the Health Assessment Questionnaire (HAQ), the Functional Index-2 (FI-2; muscle endurance), and the MAP plus disease effect on well-being on a VAS. Item fit within subscales was analyzed by Cronbach's alpha. Patients with stable disease activity filled out the MAP again 1 week later.

Results: The median combined difficulty and importance, 0-10, of the 31 items was 5.00 (range 2.10-5.95). One item was added, giving a 32-item MAP. Correlations between the median of subscales/single items of the MAP and the HAQ and disease effect on well-being were r(s) = 0.69 and r(s) = 0.68, respectively, with lower correlations to the MMT (r(s) = -0.35), and the FI-2 (r(s) = -0.29 to -0.47) and disease activity measures (r(s) = 0.36-0.41). Cronbach's alpha coefficients for the 4 subscales varied between 0.85 and 0.95. Weighted kappa coefficients (K(w)) ranged between 0.77 and 0.93 for the 4 subscales and between 0.74 and 0.83 for the 4 single items without systematic variations (p > 0.05).

Conclusion: This initial validation of the MAP indicates promising measurement properties for assessing limitations in activities of daily living and participation in patients with PM/DM in the United States.

Publication types

  • Evaluation Study

MeSH terms

  • Activities of Daily Living*
  • Adult
  • Aged
  • Dermatomyositis / diagnosis*
  • Dermatomyositis / epidemiology
  • Dermatomyositis / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Pain Measurement
  • Polymyositis / diagnosis*
  • Polymyositis / epidemiology
  • Polymyositis / physiopathology
  • Reproducibility of Results
  • Severity of Illness Index*
  • Sickness Impact Profile*
  • Surveys and Questionnaires
  • United States / epidemiology